Diagnostic and Interventional Cardiology

DANFLU-1 trial presented in a Hot Line Session at ESC Congress 2022

Innovative Randomized Trial Hints at Mortality Benefits with High-Dose Influenza Vaccines

September 2, 2022 — In an innovative, pragmatic randomized trial, high-dose influenza vaccination in older adults was ...

September 02, 2022

News | Artificial Intelligence

Artificial Intelligence Assessment of Heart Function is Superior to Sonographer Assessment

September 2, 2022 — In patients undergoing echocardiographic evaluation of cardiac function, preliminary assessment by ...

September 02, 2022

REVIVED-BCIS2 trial presented in a Hot Line Session today at ESC Congress 2022

News | Heart Failure

Coronary Stenting Does Not Benefit Patients with Severe Left Ventricular Dysfunction

September 2, 2022 — Percutaneous coronary intervention (PCI) does not reduce all-cause mortality or heart failure ...

September 02, 2022

Sponsored Content

ASCEND provides the tools that not only address the unique needs of each cardiovascular subspecialty and to care for patients from infancy into their golden years, they also innovates next-generation solutions and services that empower the provider community to truly transform their cardiovascular services

Feature | Information Technology

SPONSORED CONTENT: Unveiling the Future of Cardiovascular Workflow

Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

March 21, 2024

More than 30,271 health professionals from 174 countries attended this year’s event, which covered the entire field of cardiovascular medicine at ESC22

News | ESC

Best of ESC Congress 2022

September 1, 2022 — “At ESC Congress in Barcelona, we discussed the newest science in the light of our collective ...

September 01, 2022

Comatose patients admitted to hospital after resuscitation from out-of-hospital cardiac arrest have a significant risk of death and poor neurological outcome due to hypoxic brain injury.

News | Sudden Cardiac Arrest

Trial Finds no Benefit of Raising Blood Pressure Target in Post Cardiac Arrest Patients

September 1, 2022 — A target blood pressure of 77 mmHg provides no benefit to survival or neurological outcome in ...

September 01, 2022

ALL-HEART trial presented in a Hot Line Session at ESC Congress 2022

News | Stroke

Allopurinol Does Not Improve Cardiovascular Outcomes in Ischaemic Heart Disease Patients

September 1, 2022 — The gout medicine allopurinol has failed to reduce the primary endpoint of nonfatal myocardial ...

September 01, 2022

Sponsored Content

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability to diagnose cardiac disease with greater accuracy and precision

Feature | Cardiac Imaging

SPONSORED CONTENT: Finding the Right Solution

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...

March 05, 2024

BioIntelliSense's new BioButton for 90-days of continuous wireless temperature and vital signs monitoring on a coin-sized disposable medical device

News | Wearables

Medtronic Announces Partnership with BioIntelliSense for Exclusive U.S. Distribution of Multi-Parameter Wearable for Continuous Remote Patient Monitoring from in-Hospital to Home

August 31, 2022 — Medtronic plc, a global leader in healthcare technology, announced it has entered into a strategic ...

August 31, 2022

Healthcare providers should promote prevention of atrial fibriliation, an abnormal heart rhythm disturbance, and early interventions among both female and male patients, say Cedars-Sinai investigators. Photo by Getty Images.

News | Atrial Fibrillation

Gender Differences and AFib: New Study Flips Conventional Wisdom

August 31, 2022 — Science has long shown that men are at greater risk for developing atrial fibrillation (AFib) than ...

August 31, 2022

70-year-old White male patient with weight of 79.8 kg, BMI of 29.3, low cardiovascular risk factors (nonsmoker, no diabetes diagnosis, blood pressure of 120/78). Left: Axial CT image at level of L3 vertebral body. Right: Matching automated segmentation label map. Visceral fat area z score is 1.41, corresponding to the 92nd percentile. Patient experienced both subsequent myocardial infarction and stroke.

News | Computed Tomography (CT)

CT-Derived Body Composition With Deep Learning Predicts Cardiovascular Events

August 31, 2022 — According to ARRS’ American Journal of Roentgenology (AJR), fully automated and normalized body ...

August 31, 2022

Sponsored Content

Blog

BLOG: Combining Local Impedance with Contact Force to Perform RF Ablation

When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...

December 11, 2023

A clinician using Ultrasound Workspace from Philips

News | ESC

Philips Spotlights Integrated, Data-Driven Cardiology Solutions at ESC 2022

August 30, 2022 — Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, will showcase its latest ...

August 30, 2022

SECURE trial presented in a Hot Line Session today at ESC Congress 2022

News | ESC

Polypill Reduces Cardiovascular Events in Heart Attack Patients Compared to Usual Care

August 30, 2022 — A pill containing aspirin and medications to lower lipids and blood pressure more effectively prevents ...

August 30, 2022

The MOMENTUM 3 study showcases the significant survival benefits of Abbott's heart pump technology, particularly in a patient population with limited therapy options

News | ESC

New Data Show Abbott's Heartmate 3 Heart Pump Extends Life Beyond Five Years for Advanced Heart Failure Patients

August 30, 2022 — Abbott announced new late-breaking data that show its HeartMate 3 heart pump extends survival of ...

August 30, 2022

Sponsored Content

Case Study | Hemodynamic Monitoring Systems

TECH BRIEF — Integrated Hemodynamic Monitoring System Helps Improve Lab Performance, Efficiency

Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...

November 14, 2023

Late-breaking data presented at ESC Congress 2022 and simultaneously published in The New England Journal of Medicine confirms implant procedure safety and defibrillation success

News | Heart Failure

FARXIGA Significantly Reduced the Risk of Cardiovascular Death or Worsening of Heart Failure in Patients with Mildly Reduced or Preserved Ejection Fraction in DELIVER Phase III Trial

August 29, 2022 — Detailed results from the DELIVER Phase III trial showed AstraZeneca’s FARXIGA (dapagliflozin) ...

August 29, 2022

News | Implantable Cardioverter Defibrillator (ICD)

Medtronic Extravascular ICD meets global pivotal clinical trial’s safety and effectiveness endpoints

August 29, 2022 — Medtronic plc announced that its investigational EV ICD System – a first-of-its-kind defibrillator ...

August 29, 2022

Amarin Corporation plc announced that new REDUCE-IT data show that VASCEPA/VAZKEPA (icosapent ethyl) significantly reduced cardiovascular (CV) events in patients with a history of smoking.

News | ESC

New REDUCE-IT Data Released at ESC Oral Presentation Session

August 29, 2022 — Amarin Corporation plc announced that new REDUCE-IT data show that VASCEPA/VAZKEPA (icosapent ethyl) ...

August 29, 2022